Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Novacyt SA - Eastleigh-based biotechnology group focused on clinical diagnostics - Announces update regarding its divestment of Yourgene Health PLC’s Taiwanese subsidiary. Novacyt bought Yourgene Health in September under the condition that it has to dispose the subsidiary. Notes delay of approvals needed by the Taiwanese government regarding the divestment of Yourgene’s Taiwanese subsidiary Yourgene Health Taiwan Co Ltd to NEX Innovate Pte Ltd for up to $4 million. The takeover is also subject to a restructuring, which has been completed. ‘The various approvals have taken significantly longer to achieve than originally anticipated and management do not expect the transaction to complete by the end of 2023 as previously announced,’ Novacyt says. The company will provide a further update on the disposal at its trading update in January.
Current stock price: 61.36 pence, closed down 3.4% on Thursday in London
12-month change: down 11%
Copyright 2023 Alliance News Ltd. All Rights Reserved.